Lecture at the University of Neufchâtel, Switzerland
Jean-Pierre Tassignon, MD, PhD, CEO of Crossover, will speak about “Which expectations from the pharmaceutical industry in relation to future regulatory developments?” at the University of Neufchâtel, Switzerland, in the framework of the course in Health Law.
Public lecture at CHU Brugmann, Brussels
Prof. Anne Peretz (chair of the Clinical Research Review Committee) and Prof Jean-Pierre Tassignon (Head of the Clinical Research Unit) will give a public lecture at the auditorium P.P. Lambert of the Centre Hospitalier Universitaire Brugmann in Brussels from 12:30am through 1:30pm about “Clinical trials: utility, modalities, obstacles and successes”. Medical doctors wishing to participate register by phone at ++32-(0)2-477-2601. CME credits. Sandwich lunch.
EFGCP Annual Conference 2011, Budapest
The European Forum for GCP organizes the EFGCP Annual Conference 2011 on 1-2 February 2011 in Budapest, Hungary, at the Marriott Hotel. Jean-Pierre Tassignon will present a keynote lecture on Day 1: “Why we need harmonized training standards?”. Disparities in data quality in global clinical trials is a serious threat to the success of large Phase III trials. If all staff at all participating sites are declared suitably qualified by education, training and experience, are they really “equally” qualified? Can something be done to harmonize the qualifications of clinical teams, and thereby reduce the formidable challenges we face with pooling medical data from around the world?
Annual Conference of the Association of Belgian Hospitals in Brussels
Crossover is represented at the Annual Conference of ABH-BVZ with a poster which provides a status report after two years of developing the Crossover model of a central Clinical Research Unit at University Hospital Brugmann and at Queen Fabiola Children’s University Hospital. To see the poster, please click on the link to the publications section of this website.
BEAPP 4th Annual Scientific Conference on 18 March 2010, Diamant Center, Brussels
The Belgian Association of Pharmaceutical Physicians organizes its 4th Annual Scientific Conference at the Diamant Center in Brussels on 18MAR2010. Crossover is represented with a speaker on the program. Jean-Pierre Tassignon, Visiting Professor and Head of the Crossover Clinical Research Unit at University hospitals Brugmann (adults and maternity) and HUDERF (pediatric hospital) in Brussels will give a lecture on “Patient Recruitment: Too Difficult in Belgium?”. Jean-Pierre will indicate that Belgium is the most intensive country in terms of new clinical trials set up per million inhabitants per year. Clouds are gathering over the validity of pooling indiscriminately clinical data from any country in the world, particularly where GDP per capita is much lower than in the EU/US, where access to the standard of care available in OECD countries is not effectively available to patients outside clinical trials, where the risk of counterfeit concomitant medications is significant, where clinical trial participants have no access in practice to defend themselves in the courts, where there is little or no inspection of clinical trials by the competent authorities, etc. Hence, large hospitals in economically advanced countries with a strong clinical research tradition become the more valuable. They screen the population within the radius they serve day in day out with the most advanced technology available, and therefore identify the niche patients suitable for current hyper-selective protocols in terms of admissible patients. With a properly functioning clinical research unit, large hospitals can accommodate more trials and minimize the project management syndrome of zero-enrolling sites.